Effect of Single Intravenous Injection of Esketamine on Postpartum Depression after Labor Analgesia and Potential Mechanisms: A Randomized, Double-blinded Controlled Trial

Research Square June 30, 2023 preprint DOI: 10.21203/rs.3.rs-3100226/v1 (opens in new tab)

Study at a glance

AI-extracted from the abstract

Characteristics	Randomized controlled trial Double-blind
Intervention	Esketamine
Topics	Depression Esketamine

Abstract

Effect of Single Intravenous Injection of Esketamine on Postpartum Depression after Labor Analgesia and Potential Mechanisms: A Randomized, Double-blinded Controlled Trial

Effect of pre-administration of esketamine intraoperatively on postpartum depression after cesarean section: A randomized, double-blinded controlled trial. Medicine (Baltimore) March 1, 2023
Effects of different doses of esketamine intervention on postpartum depressive symptoms in cesarean section women: A randomized, double-blind, controlled clinical study. J Affect Disord July 11, 2023
Single low-dose esketamine improves postpartum depression symptoms and recovery quality in cesarean section women. American Journal of Translational Research 2026
Efficacy of a single low dose of esketamine after childbirth for mothers with symptoms of prenatal depression: randomised clinical trial. BMJ (Clinical research ed.) April 10, 2024 64 citations
Effect of esketamine on serum neurotransmitters in patients with postpartum depression: a randomized controlled trial. BMC Anesthesiology August 19, 2024 11 citations

Study at a glance

Abstract

Related reading